InnoHealth Australia 2017-2019 – en route with InnoTour 2018: Sixteen Australian researchers. Five days. Eight cities.

Press release / October 12, 2018

(Sankt Augustin and Hannover, Germany) The last event within the Fraunhofer initiative InnoHealth Australia will take place in Germany from November 5 to 9: InnoTour 2018. It will lead a group of 16 Australian researchers and innovators to different German research institutions and SMEs of the healthcare sector, presenting the wide spectrum of applied research throughout the country. The tour focuses on establishing a vivid network between the German and Australian healthcare sectors following the initiative’s goal of strengthening the cooperation for potential research and business projects.

The initiative is a constituent part of the collaborative project “International Research Marketing“ funded by the German Federal Ministry of Research and Education (BMBF) under the brand “Research in Germany“ and executed by the Fraunhofer-Gesellschaft in the period 2017-2019.

Starting point of InnoTour 2018 will be the Fraunhofer headquarters in Munich. Dr. Lutz Zeitlmann, Head of Research Coordination Materials, Life Sciences, will welcome the Australian experts, introducing them to the Fraunhofer world of high-tech development. In the afternoon, the group will visit the Medical Valley/Digital Hub in Erlangen, where Jörg Trinkwalter, member of the Managing Board, will introduce the researchers to interdisciplinary groups working on improving ways for globally operating companies and SMEs to accelerate the time to market for their medical device products. A central point of this – and the following – stop of InnoTour will be exchanging ideas and looking for possible connecting points.

In Stuttgart on the next day, Fraunhofer IGB (Institute for Interfacial Engineering and Biotechnology) will give insights into processes and technologies in the business fields of healthcare, nutrition, environment, and sustainable and functional products being developed and optimized there. After networking, the group will have a stop at Pharmacy Museum Heidelberg.

Fraunhofer IPA (Institute for Manufacturing Engineering and Automation) in Mannheim will present its project group PAMB. It develops novel automation solutions for medicine and biotechnology in a wide spectrum of research and development services. The Max Planck Institute (MPI) for Experimental Medicine in Göttingen, which the delegation will visit next, stands for basic research in neurosciences and oncology.

Day 4 of InnoTour 2018 will be at Fraunhofer ITEM (Institute for Toxicology and Experimental Medicine) in Hannover. This stop will include a visit to the adjacent Clinical Research Center Hannover (CRC Hannover), whose state-of-the-art infrastructure is being shared by Fraunhofer ITEM, the Hannover Medical School (MHH) and the Helmholtz Center for Infection Research (HZI) to perform safety and efficacy trials with candidate drugs, patient-oriented research, and epidemiological studies.

On the last morning, the Australian experts will visit the Fraunhofer-inHaus-Center in Duisburg, an innovation center for novel system solutions in rooms and buildings. Stryker GmbH, in Duisburg as well, will be the last stop of the tour. Markus Wiegmann, Managing Director, will welcome the Australian group, presenting the company’s activities in the field of medical technology.

Contact at Fraunhofer-Gesellschaft:

Heike Wülfing
Fraunhofer-Gesellschaft

International Research Marketing | InnoHealth Australia
Schloss Birlinghoven
53754 Sankt Augustin, Germany
Phone +49 2241 14 1576
E-mail: innohealth@fraunhofer.de

Further information:

Project website of Research in Germany

InnoTour Germany 2018

Project InhalDrugTest

Press release

InnoHealth Australia 2017-2019 – en route with InnoTour 2018: Sixteen Australian researchers. Five days. Eight cities.

Project InhalDrugTest

Contact Press / Media

Dr. Cathrin Nastevska

Contact Press / Media

Dr. Tanja Hansen